• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏复律除颤器使用中的种族和民族差异:当代综述

Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review.

作者信息

Tertulien Tarryn, Bush Kelvin, Jackson Larry R, Essien Utibe R, Eberly Lauren

机构信息

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Division of Cardiology, San Antonio Military Medical Center, Fort Sam Houston, TX, USA.

出版信息

Curr Treat Options Cardiovasc Med. 2023 Dec;25(12):771-791. doi: 10.1007/s11936-023-01025-z. Epub 2023 Dec 20.

DOI:10.1007/s11936-023-01025-z
PMID:38873495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11172403/
Abstract

PURPOSE OF REVIEW

Sudden cardiac arrest is associated with high morbidity and mortality. Despite having a disproportionate burden of sudden cardiac death (SCD), rates of primary and secondary prevention of SCD with implantable cardioverter-defibrillator (ICD) therapy are lower among eligible racially minoritized patients. This review highlights the racial and ethnic disparities in ICD utilization, associated barriers to ICD care, and proposed interventions to improve equitable ICD uptake.

RECENT FINDINGS

Racially minoritized populations are disproportionately eligible for ICD therapy but are less likely to see cardiac specialists, be counseled on ICD therapy, and ultimately undergo ICD implantation, fueling disparate outcomes. Racial disparities in ICD utilization are multifactorial, with contributions at the patient, provider, health system, and structural/societal level.

SUMMARY

Racial and ethnic disparities have been demonstrated in preventing SCD with ICD use. Proposed strategies to mitigate these disparities must prioritize care delivery and access to care for racially minoritized patients, increase the diversification of clinical and implementation trial participants and the healthcare workforce, and center reparative justice frameworks to rectify a long history of racial injustice.

摘要

综述目的

心脏骤停与高发病率和死亡率相关。尽管在心脏性猝死(SCD)方面负担不成比例,但在符合条件的少数族裔患者中,植入式心脏复律除颤器(ICD)治疗对SCD的一级和二级预防率较低。本综述强调了ICD使用方面的种族和族裔差异、ICD治疗的相关障碍以及为提高ICD公平使用率而提出的干预措施。

最新发现

少数族裔人群接受ICD治疗的比例过高,但他们看心脏专科医生、接受ICD治疗咨询并最终接受ICD植入的可能性较小,这导致了不同的结果。ICD使用方面的种族差异是多因素的,在患者、提供者、卫生系统以及结构/社会层面都有影响。

总结

在使用ICD预防SCD方面已证实存在种族和族裔差异。为减轻这些差异而提出的策略必须优先考虑为少数族裔患者提供护理和获得护理的机会,增加临床和实施试验参与者以及医疗保健劳动力的多样性,并以修复性司法框架为核心,以纠正长期存在的种族不公正历史。

相似文献

1
Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review.植入式心脏复律除颤器使用中的种族和民族差异:当代综述
Curr Treat Options Cardiovasc Med. 2023 Dec;25(12):771-791. doi: 10.1007/s11936-023-01025-z. Epub 2023 Dec 20.
2
Racial and ethnic differences in implantable cardioverter-defibrillator patient selection, management, and outcomes.植入式心脏复律除颤器患者选择、管理及预后方面的种族和民族差异。
Heart Rhythm O2. 2022 Dec 16;3(6Part B):807-816. doi: 10.1016/j.hroo.2022.09.003. eCollection 2022 Dec.
3
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用:基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
4
Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology.通过创新设计(VIVID)试验减少 ICD 治疗中的种族差异的视频:合理性、设计和方法。
Am Heart J. 2020 Feb;220:59-67. doi: 10.1016/j.ahj.2019.10.011. Epub 2019 Nov 11.
5
Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality.射血分数降低的心力衰竭患者中一级预防植入式心脏复律除颤器使用的预测因素:心脏性猝死和全因死亡率预测风险的影响
Eur J Heart Fail. 2022 Jul;24(7):1212-1222. doi: 10.1002/ejhf.2530. Epub 2022 May 22.
6
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis.沙库巴曲缬沙坦与心脏性猝死的关系:根据植入式心脏复律除颤器的使用和心力衰竭病因的分析:PARADIGM-HF 研究
JACC Heart Fail. 2020 Oct;8(10):844-855. doi: 10.1016/j.jchf.2020.06.015. Epub 2020 Sep 9.
7
Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.心力衰竭住院患者植入式心脏复律除颤器咨询与使用中的性别及种族/民族差异:来自“遵循指南-心力衰竭”项目的发现
Circulation. 2016 Aug 16;134(7):517-26. doi: 10.1161/CIRCULATIONAHA.115.021048. Epub 2016 Aug 4.
8
Disparities in the implantation of secondary prevention implantable cardioverter defibrillator in the United States.美国二级预防植入式心脏复律除颤器植入的差异。
Pacing Clin Electrophysiol. 2024 Sep;47(9):1241-1251. doi: 10.1111/pace.15043. Epub 2024 Jul 5.
9
A Comparative Study Between Amiodarone and Implantable Cardioverter-Defibrillator in Decreasing Mortality From Sudden Cardiac Death in High-Risk Patients: A Systematic Review and Meta-Analysis.胺碘酮与植入式心脏复律除颤器降低高危患者心源性猝死死亡率的比较研究:一项系统评价和荟萃分析。
Cureus. 2022 Jun 16;14(6):e26017. doi: 10.7759/cureus.26017. eCollection 2022 Jun.
10
Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis.心力衰竭患者植入式心脏复律除颤器的使用不足——心脏性猝死预防的现状
Indian Pacing Electrophysiol J. 2015 Apr 1;15(1):20-9. doi: 10.1016/S0972-6292(16)30838-5. eCollection 2015 Jan-Feb.

本文引用的文献

1
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry.在照顾大量黑人群体的医院中,心力衰竭患者的护理质量和临床结局:遵循指南-心力衰竭注册研究。
JAMA Cardiol. 2023 Jun 1;8(6):545-553. doi: 10.1001/jamacardio.2023.0695.
2
Facilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest : A Randomized Clinical Trial.促进有发生心源性猝死风险的黑人患者进行共同决策:一项随机临床试验。
Ann Intern Med. 2023 May;176(5):615-623. doi: 10.7326/M22-2934. Epub 2023 Apr 4.
3
Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study.种族不平等在考虑护理偏好后仍然存在于心室辅助装置和移植的获得中:REVIVAL 研究的报告。
Circ Heart Fail. 2023 Jan;16(1):e009745. doi: 10.1161/CIRCHEARTFAILURE.122.009745. Epub 2022 Oct 19.
4
Racial Disparities in Cardiovascular Risk and Cardiovascular Care in Women.女性心血管风险和心血管护理中的种族差异。
Curr Cardiol Rep. 2022 Sep;24(9):1197-1208. doi: 10.1007/s11886-022-01738-w. Epub 2022 Jul 8.
5
Association of Race and Ethnicity on the Management of Acute Non-ST-Segment Elevation Myocardial Infarction.种族和民族与急性非 ST 段抬高型心肌梗死管理的关联。
J Am Heart Assoc. 2022 Jun 21;11(12):e025758. doi: 10.1161/JAHA.121.025758. Epub 2022 Jun 14.
6
Primary Care Appointment Completion Rates and Telemedicine Utilization Among Black and Non-Black Patients from 2019 to 2020.2019 年至 2020 年黑人和非黑人患者的初级保健预约完成率和远程医疗利用率。
Telemed J E Health. 2022 Dec;28(12):1786-1795. doi: 10.1089/tmj.2022.0104. Epub 2022 May 2.
7
Inclusion and diversity in clinical trials: Actionable steps to drive lasting change.临床试验中的纳入和多样性:推动持久变革的可行步骤。
Contemp Clin Trials. 2022 May;116:106740. doi: 10.1016/j.cct.2022.106740. Epub 2022 Mar 29.
8
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
9
Impact of an Automated Best Practice Alert on Sex and Race Disparities in Implantable Cardioverter-Defibrillator Therapy.自动最佳实践警报对植入式心脏复律除颤器治疗中性别和种族差异的影响。
J Am Heart Assoc. 2022 Apr 5;11(7):e023669. doi: 10.1161/JAHA.121.023669. Epub 2022 Mar 18.
10
Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease.种族、种族主义与心血管健康:应用健康社会决定因素框架分析心血管疾病的种族/民族差异。
Circ Cardiovasc Qual Outcomes. 2022 Jan;15(1):e007917. doi: 10.1161/CIRCOUTCOMES.121.007917. Epub 2022 Jan 18.